Gumokimab
古莫奇单抗
Report date: 2026/03/19 20:00:18
Base Information
Drug NameGumokimab
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesZhongshan Akeso Biopharma Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesAkeso Pharmaceuticals IncZhongshan Akeso Biopharma Co Ltd
Inactive CompaniesAkesobio Australia Pty Ltd
Active Indications +[5]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A